Home › Funds › DME Capital Management, LP › NUVB

DME Capital Management, LP position in NUVB

NUVATION BIO INC · Health Care

DME Capital Management, LP reported holding 34,995 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$196K, representing 0.01% of its reported portfolio and ranking #45 among its reported holdings. DME Capital Management, LP has disclosed NUVB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)34.99K sh
Reported value held$195.97K
Portfolio Weight0.01%
First reportedQ1 2024
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How DME Capital Management, LP's NUVB position evolved

DME Capital Management, LP first disclosed a stake in NUVB in Q1 2024 at 34,995 shares (US$127K). The position peaked in Q4 2025 at 34,995 shares, worth US$314K. Across 11 filings, DME Capital Management, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 34,995 shares valued at US$196K.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 34.99K $127.38K New
Q2 2024 34.99K $102.19K Hold
Q3 2024 34.99K $80.14K Hold
Q4 2024 34.99K $93.09K Hold
Q1 2025 34.99K $61.59K Hold
Q2 2025 34.99K $68.24K Hold
Q3 2025 34.99K $129.48K Hold
Q4 2025 34.99K $313.56K Hold
Q1 2026 34.99K $150.13K Hold
Q2 2026 34.99K $198.77K Hold
Q3 2026 34.99K $195.97K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVB and 13F data

NUVB (NUVATION BIO INC) is a Health Care company. 56 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$145.3M), Context Capital Management, LLC (US$53.1M), Laurion Capital Management LP (US$43.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVB

All NUVB fund holders →

FAQ

How long has DME Capital Management, LP held NUVB?

DME Capital Management, LP has disclosed NUVB holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is DME Capital Management, LP's current position in NUVB?

As of Q3 2026, DME Capital Management, LP holds 34.99K shares of NUVB (NUVATION BIO INC), valued at $195.97K, representing 0.01% of its reported portfolio and ranking #45.

Has DME Capital Management, LP been buying or selling NUVB?

In the latest 13F filing (Q3 2026), DME Capital Management, LP held unchanged its position in NUVB. The position peaked in Q4 2025 at 34.99K shares.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Laurion Capital Management LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.